Cargando…
Identification of Target Genes Related to Sulfasalazine in Triple-Negative Breast Cancer Through Network Pharmacology
BACKGROUND: The anti-inflammatory drug sulfasalazine (SAS) has been confirmed to inhibit the growth of triple-negative breast cancer (TNBC), but the mechanism is not clear. The aim of this study was to use network pharmacology to find relevant pathways of SAS in TNBC patients. MATERIAL/METHODS: Thro...
Autores principales: | Yu, Haochen, Hu, Ke, Zhang, Tao, Ren, Haoyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7513616/ https://www.ncbi.nlm.nih.gov/pubmed/32925871 http://dx.doi.org/10.12659/MSM.926550 |
Ejemplares similares
-
Identification of a DNA Methylation-Based Prognostic Signature for Patients with Triple-Negative Breast Cancer
por: Gao, Yinqi, et al.
Publicado: (2021) -
Identification of Genes with Prognostic Value in the Breast Cancer Microenvironment Using Bioinformatics Analysis
por: Ren, Haoyu, et al.
Publicado: (2020) -
Systems Pharmacology-Based Identification of Mechanisms of Action of Bolbostemma paniculatum for the Treatment of Hepatocellular Carcinoma
por: Wang, Lan-Lan, et al.
Publicado: (2021) -
Identification of the Active Compounds and Significant Pathways of Artemisia Annua in the Treatment of Non-Small Cell Lung Carcinoma based on Network Pharmacology
por: Zhang, Shu Qiao, et al.
Publicado: (2020) -
Stemness signature and targeted therapeutic drugs identification for Triple Negative Breast Cancer
por: Gul, Samina, et al.
Publicado: (2023)